Literature DB >> 22550293

Oncogenomics methods and resources.

Simon J Furney, Gunes Gundem, Nuria Lopez-Bigas.   

Abstract

Today, cancer is viewed as a genetic disease and many genetic mechanisms of oncogenesis are known. The progression from normal tissue to invasive cancer is thought to occur over a timescale of 5-20 years. This transformation is driven by both inherited genetic factors and somatic genetic alterations and mutations, and it results in uncontrolled cell growth and, in many cases, death. In this article, we review the main types of genomic and genetic alterations involved in cancer, namely copy-number changes, genomic rearrangements, somatic mutations, polymorphisms, and epigenomic alterations in cancer. We then discuss the transcriptomic consequences of these alterations in tumor cells. The use of "next-generation" sequencing methods in cancer research is described in the relevant sections. Finally, we discuss different approaches for candidate prioritization and integration and analysis of these complex data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22550293     DOI: 10.1101/pdb.top069229

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  5 in total

1.  Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention.

Authors:  William P Katt; Marc A Antonyak; Richard A Cerione
Journal:  Mol Pharm       Date:  2014-12-10       Impact factor: 4.939

2.  Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study.

Authors:  Nadine Bonberg; Beate Pesch; Thomas Behrens; Georg Johnen; Dirk Taeger; Katarzyna Gawrych; Christian Schwentner; Harald Wellhäußer; Matthias Kluckert; Gabriele Leng; Michael Nasterlack; Christoph Oberlinner; Arnulf Stenzl; Thomas Brüning
Journal:  BMC Cancer       Date:  2014-11-20       Impact factor: 4.430

3.  BIOMAP: A Home for All Biology Methods.

Authors:  Silvia Ayora
Journal:  Biol Methods Protoc       Date:  2016-02-29

4.  LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types.

Authors:  Jung H Kim; Alla Karnovsky; Vasudeva Mahavisno; Terry Weymouth; Manjusha Pande; Dana C Dolinoy; Laura S Rozek; Maureen A Sartor
Journal:  BMC Genomics       Date:  2012-10-04       Impact factor: 3.969

Review 5.  Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.

Authors:  Mohamed Shehata Draz; Binbin Amanda Fang; Pengfei Zhang; Zhi Hu; Shenda Gu; Kevin C Weng; Joe W Gray; Fanqing Frank Chen
Journal:  Theranostics       Date:  2014-06-11       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.